scorecardresearch
Add as a preferred source on Google
Wednesday, October 1, 2025
TopicPharmaceuticals

Topic: Pharmaceuticals

A needle in the eye promises improved treatment for blinding glaucoma

Projected to affect about 80 million people by 2020, the condition causes progressive loss of peripheral vision which ultimately leads to blindness.

Next blockbuster drugs should include existing ones

A growing crop of research, including a New England Journal of Medicine study, suggests there are gains to be made by better using drugs we already have.

Indian pharma firms lukewarm on China’s lowered drug tariffs considering lengthy approvals

The announcement was made to provide opening to Indian pharmaceutical firms to market their economically priced drugs.

Patanjali is under the scanner once again for ‘post-dating’ their products

According to Facebook and Twitter users, boxes of the ayurvedic product that bore a ‘May 2018’ manufacturing date were found on counters in April.

India’s import of China-made medicines has increased 50 per cent in 4 years

The export of pharmaceuticals, especially generics and drug formulations, is one of India’s strengths. But China has been steadily eroding India’s advantage.

Trader’s margin on drugs for rare diseases may be cut to 30% from 4,000%

The treatment of rare diseases requires medicines categorised as ‘orphan’ drugs, which are mostly imported and cost a patient anything between Rs 50 lakh and Rs 4 crore per year.

The reinvention of Indian drug-makers: They’re now selling FMCG products

Top pharma firms have recently launched over-the-counter products like sanitary pads and body washes. They’re even poaching FMCG talent to market them.

On Camera

Jana Sangh leader VK Malhotra brought Advani to Delhi, kept the party afloat after 1984 setback

Unlike his colleagues from the time of the BJS, several of whom became governors and held other constitutional posts, Malhotra chose to lead a quiet and simple retired life after the massive 2014 victory of the BJP.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

In Nepal, young dreams of serving in Indian Army crash as Agnipath halts a centuries-old tradition

Since 1815, Nepali Gorkhas have served in Indian & British Armies, as well as in Bihar, Bengal & Assam Police. Since Agnipath scheme came in, no Nepal-domiciled Gorkha has enlisted.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.